Is Mounjaro a GLP-1 Medicine? The Plain Answer (October 2026)

01 · The answer

So, is Mounjaro a GLP-1 drug or something different?

Mounjaro is a GLP-1 medicine, and it is also a GIP medicine. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ If someone asks whether it is "a GLP-1", the reply is: yes, it acts on that receptor, and it also acts on the GIP receptor. The same applies to the question "is tirzepatide a GLP-1?" Tirzepatide is the active ingredient, and Mounjaro is the brand name Eli Lilly sells it under.

In everyday conversation, people use "GLP-1" as shorthand for the whole group of weekly weight-management injections. Used that way, Mounjaro is included. Used strictly, as the name of a single receptor target, Mounjaro goes beyond it.

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ We explain the mechanism in more detail on our page about Mounjaro as a GLP and GIP medicine, and our GLP and Mounjaro guide covers the wider family.

02 · Your decision

What should you do with this information?

For most readers the useful question is not the label but whether treatment is right for them. Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes, and it is used alongside a reduced-calorie diet and increased physical activity. It is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber.¹

If you are comparing options, think about three things. First, your own medical history, which only a prescriber can weigh up. Second, whether you want a once-weekly pen, which both Mounjaro and Wegovy are. Third, how you will fund treatment, because access on the NHS is phased while private supply is available now.

When you are ready, you can see current doses and costs on the Mounjaro pen page, where the free consultation starts. A new customer's first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). Our weight loss clinic page explains the wider service.

03 · Reality check

What "GLP-1" does and does not tell you about a medicine

The label tells you which hormone pathway a medicine uses. It does not tell you how strong the effect is, how well you will tolerate it, or whether it suits your health history. Two medicines can share a label and still differ in dose steps, side-effect profile and trial results. That is why it helps to read the specific product information rather than treating "GLP-1" as a single product.

It also does not mean every product sold under that banner is licensed. Be wary of supplements marketed as "natural GLP-1" alternatives: they are low-cost supplements with no clinical oversight, their dosing is not standardised, and they are not the same as a regulated prescription medicine. If a seller offers any weight-loss injection without a consultation or prescription, walk away.

Finally, remember that the label does not replace a conversation. A prescriber can look at your conditions, other medicines and goals, and tell you whether a GLP-1 medicine, a dual GIP and GLP-1 medicine, or a different approach makes sense. That review is part of our free consultation, which carries no charge and no obligation.

04 · What GLP-1 actually means

What GLP-1 actually means

GLP-1 is the name of a natural gut hormone, and by extension the name used for a group of medicines that copy its action. Think of it like asking whether "statin" is the same as one particular tablet. One is the family, the other is a member.

The medicine side of the story is easiest to follow through receptors. Receptors are docking points on cells that respond when the right hormone, or a medicine shaped to fit, attaches. Tirzepatide activates two of these receptors, GIP and GLP-1, while semaglutide is a single-action medicine on this pathway. So the phrase "GLP-1 medicine" can cover products with quite different designs.

What do these receptors do in practice? Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That last point matters: the medicine is an aid to a reduced-calorie diet and increased physical activity, not a replacement for them.

Medicines in the GLP-1 family are not interchangeable. Their doses, schedules and trial results differ, and your prescriber chooses between them based on you.

Our page on the GLP-2 and tirzepatide question clears up a related naming confusion.

One last practical point on terminology. You will see Mounjaro called a "weight-loss jab", an "incretin mimetic" or a "GLP-1 agonist" in different places. These are different ways of pointing at the same medicine. The licensed facts, which are what matter for your safety, are in the product information and the patient information leaflet, and we encourage you to read both before starting.¹³ If anything in them is unclear, ask the prescribing team, who can explain it in plain language.

05 · Dual action explained

Why the GIP part makes Mounjaro different

The GIP action is what separates Mounjaro from semaglutide-based pens. Tirzepatide activates GIP and GLP-1 receptors at once, whereas semaglutide activates GLP-1 alone.¹ That is a difference in design, and design differences are worth understanding even if the day-to-day experience of a weekly injection looks similar.

It is tempting to assume that an extra receptor automatically means a better result for every individual. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages: individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

How does the dual action show up in what you feel? As described in the product information, most people feel fuller sooner and less hungry between meals.¹ The slowed stomach emptying is part of that. It is also the reason for a specific caution about oral contraceptives: the medicine can reduce absorption of oral contraceptives because stomach emptying slows.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you use the pill, discuss this with your prescriber before you start.

It is worth being careful with comparisons. Only a head-to-head trial can fairly compare two medicines.

The practical upshot: the dual action is a genuine design feature and a good reason Mounjaro is discussed separately from semaglutide, but it is not a promise of any specific outcome for you. Your response depends on your dose, your diet, your activity, your health and how well you tolerate the medicine. The prescribing team reviews progress in the ongoing monthly clinical reviews included with treatment, adjusts the dose through titration, and supports you with side effects.

Mounjaro is supplied in strengths of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg, and you step up over time rather than starting high.¹ The starter strength is a settling-in dose and the strengths above it are reached through prescriber-led titration. You can read more about how a pen is used in our guide on how many injections are in one Mounjaro pen.

06 · Mounjaro vs Ozempic and Wegovy

Mounjaro vs Ozempic and Wegovy: which is safer?

Neither is automatically safer: Mounjaro, Wegovy and Ozempic are all licensed medicines, and the safer choice is the one your prescriber judges suitable for your health history.

First, the chemistry. Mounjaro contains tirzepatide; Wegovy and Ozempic contain semaglutide. Tirzepatide activates GIP and GLP-1 receptors, and semaglutide activates GLP-1 alone.¹ Both are once-weekly injections.

Second, the licences. In the UK, Mounjaro is licensed for weight management in adults and for type 2 diabetes.¹ Wegovy is the semaglutide brand used for weight management, with a dose ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly. Ozempic is semaglutide licensed for type 2 diabetes. It is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. Mounjaro's own ladder runs from 2.5mg up to 15mg. If you want to see Wegovy details, look at the Wegovy pen page.

Third, the head-to-head evidence. Only SURMOUNT-5, the first large head-to-head trial, directly compares tirzepatide with semaglutide for weight loss.¹⁵

Fourth, side effects and suitability. Each product has its own list of side effects and cautions in its product information, and the patient information leaflet for Mounjaro is the place to read the full list.¹³ Your prescriber will ask about existing conditions and other medicines because these can change which option is appropriate. Medicines such as insulin or sulfonylureas may need dose adjustments when used with Mounjaro because of low blood sugar risk, so tell the prescriber about any diabetes treatment.

Fifth, practicalities. Price, pen size, dosing steps and availability differ, and these things can matter as much as the receptor story.

If you are thinking of switching between them, do not do so on your own. Speak to a prescriber, who will advise on a sensible starting dose for the new medicine. Do not combine them. The safest way to a decision is a consultation where all your details are on the table, and ours is free with no obligation.

07 · Tablets and daily injections

Other GLP-1 products: tablets and daily injections

Not every GLP-1 product is a weekly pen. The family now includes tablets and older daily injections, and it helps to know how they sit alongside Mounjaro so you can interpret headlines correctly.

Liraglutide, sold as Saxenda and in other products, is supplied at a concentration of 6mg per millilitre and is a daily injection, unlike once-weekly Mounjaro and Wegovy. That difference in schedule is the main practical contrast: a daily routine versus a weekly one. Beyond that, figures for liraglutide vary, and your prescriber can advise on how it fits your situation.

Tablets are newer. Wegovy tablets contain oral semaglutide and are described in their own product information.²⁰ Foundayo is an orforglipron tablet with its own product information too.²¹ Orforglipron is the generic name for an oral small-molecule medicine that acts on the GLP-1 receptor. Because these are separate products with separate trials, their results should not be compared with Mounjaro's as if they were head to head. For current Wegovy options, see the Wegovy pen page and our weight loss pages.

What does this mean if you are choosing? A few honest considerations:

• Some people prefer a tablet to an injection and will ask about that first.
• Others like the simplicity of a single weekly dose and find a pen easy to fit into the week.
• A daily injection asks for a daily habit, which suits some people and not others.
• The mechanism matters less to most people than how well they tolerate the medicine and how realistically they can stick to it.

None of these considerations makes one product universally better. They are lifestyle questions to put to your prescriber. A good consultation covers what you have tried before, what you would be willing to do weekly or daily, and what your health history allows.

It is also worth saying that each of these medicines is used alongside a reduced-calorie diet and increased physical activity. No tablet or injection removes the need for that. If a seller promises dramatic weight-loss claims with no effort, treat that as a red flag.

Finally, remember that tirzepatide's dual GIP and GLP-1 action is what the product information highlights as distinct from semaglutide.¹ The tablets and the daily injection sit elsewhere in the family. When a headline says "new GLP-1 pill", it is describing a different product altogether and tells you little about Mounjaro.

08 · How well it works and how quickly

How quickly does Mounjaro work, and how well?

Mounjaro starts acting on appetite signals soon after treatment begins, but the full weight-management effect builds over many months of dose steps rather than days. Most people feel fuller sooner and less hungry between meals.¹

The starter pen is a settling-in step. Our guide to what to expect on day one of Mounjaro walks through the first injection.

On size of effect, here is the trial headline. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

To make that concrete, for someone starting at 100 kg, 20.9% is about 21 kg. That is a worked example of an average, not a forecast. Trial averages do not predict your own result, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

Why do people respond differently? Appetite, activity, sleep, other medicines, medical conditions and how consistently someone follows the plan all play a part. A prescriber also adjusts the dose to balance benefit and tolerability, so a slower step-up is not a failure. If you find your appetite is still strong, or the opposite, that you feel too full, tell the team at your review. They can adjust.

Does a pen last long enough to carry you through a dose step? Each pen is designed for a four-week course, a point covered in our page on whether one Mounjaro pen lasts a month. Do not stretch, split or otherwise change how a pen is used, and never take extra doses. Follow the pen's instructions and your prescriber's advice.

Honest expectations are the best start. The medicine helps with appetite; you still need to build habits around food and movement.

09 · NHS or private access

NHS or private: how do you get Mounjaro in the UK?

You can get Mounjaro either through the NHS, where access is phased, or through regulated private treatment, which is available now. Mounjaro is available on the NHS, but access is being phased in over several years.⁴ NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you want to explore the NHS route, speak to your GP and read the NHS guide to tirzepatide.⁵ That is the right place to find out where you sit in the phased rollout. NHS prescriptions in England carry the standard prescription charge of £9.90 per item unless you are exempt, though your GP can tell you how that applies to you.

For private treatment, the route is a consultation with a pharmacy whose registration you can check. We are a GPhC-registered UK online pharmacy, registration 9012878, and you can verify us on the public register.¹² Our process works like this:

• Free online consultation: a short health questionnaire with no charge and no obligation.
• Prescriber review: reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and dispatch: dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm.
• Delivery: free next-day tracked delivery in temperature-controlled, discreet packaging. Saturday delivery is £14.99.

On supply, our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. All six strengths are in stock. That matters because counterfeit pens are a real risk when buying from unregulated sellers. The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme, and you can use both to stay informed.⁷ Any site offering to supply without a consultation or prescription should be avoided.

On cost, a first 2.5mg pen costs £129.99 for new customers with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price, applied with code DOSE25. A first year costs £2,711.88 at standard prices if you settle at 5mg, up to £3,599.88 at 15mg, before discounts. Prices were checked 10 October 2026. You can see the live doses on the Mounjaro pen page.

Across the UK pharmacies we track, the cheapest and dearest Mounjaro pens ranged from £143.96 to £339.00 per month as of 10 October 2026, and Boots' dose prices sat between £179.00 and £339.00.

10 · Safety and long-term use

Safety, long-term effects and what is new

Mounjaro is a licensed prescription medicine, and its safety information lives in the product information and patient leaflet, which you should read before starting.¹³

What about long-term effects? Our aftercare includes ongoing monthly clinical reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability, and there is no auto-shipping, so you stay in control of continuing.

If you notice a new symptom, tell your prescriber. You can also report suspected side effects through the MHRA Yellow Card scheme, which helps regulators monitor medicines.¹⁹ Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷ If you have concerns about your mood, tell your prescriber and seek help promptly.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

Some safety points are specific and worth knowing:

• Contraception: the medicine can reduce absorption of oral contraceptives because stomach emptying slows, so switch to a non-oral method, or add a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.⁷
• Diabetes medicines: insulin or sulfonylureas may need dose adjustments because of low blood sugar risk, so always disclose them.
• Stopping: tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system, there is no way to speed this up, and nothing needs doing while it clears.¹

Storage matters too. Store unopened pens in the fridge at 2–8°C until first use, and they keep until the printed expiry date. Once in use, a KwikPen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. For any unopened-pen question beyond that, check the patient information leaflet or ask the pharmacy.¹³

What about "new rules"? The honest summary: NHS access is being phased in, and Eli Lilly raised the UK list price of Mounjaro, which is why private prices differ from what many people remember.¹⁰ Pharmacy sell prices vary because of confidential discounts, and ours are shown live on the product page.

This page is information, not a substitute for medical advice. Individual results vary, and a consultation reviewed by a GPhC-registered prescriber is the place to discuss your own circumstances. Our team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk or phone on 0333 207 0413.

11 · Choosing and tracking treatment

Choosing, starting and tracking treatment

Once you know Mounjaro is a GLP-1 medicine with a GIP action, the next step is deciding whether to explore it, and then keeping track of how treatment goes. A sensible approach has a few parts.

Start by checking the eligibility basics. Mounjaro is licensed for weight management in adults, used with a reduced-calorie diet and increased physical activity.¹ NHS criteria are stricter and based on BMI and weight-related conditions. The prescriber decides what is appropriate for you, and you should answer the questionnaire truthfully.

Next, prepare questions for your review. Useful ones include: which dose will I start on, how will we decide when to step up, what should I do if I feel unwell after an injection, how do I handle a missed dose, and how will we review progress. Write them down, because it is easy to forget in the moment.

Then think about habits. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Planning meals, protein and movement in advance helps you use the appetite change well. Many people find that smaller, regular meals suit them as the stomach empties more slowly. Ask your prescriber for tailored advice rather than relying on generic internet lists.

Tracking helps. Our free companion app, GLPTrackr, is available for iOS and Android and helps you record your injections, doses and progress. Bring those notes to your monthly review. Seeing patterns over time is more useful than judging by a single day on the scales.

Weight management is a long-term effort, and decisions about continuing or stopping belong in a conversation with your prescriber.

On payment, we accept Visa and Mastercard, Klarna and pay-monthly options, with no subscriptions, so you are never locked in. Prescription medicines that have been dispensed cannot be returned except when faulty, damaged or the wrong item, which you should report within 3 days. Declined consultations are refunded in full automatically.

If you are ready to take a step, start with the free consultation on the Mounjaro pen page, or explore our weight loss clinic for the wider picture. If you are still reading and comparing, that is fine too. A well-informed decision is better than a rushed one.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹